Behavioral variation across multiple phases of intravenous cocaine self-administration among genetically diverse mouse populations.

IF 3.3 3区 医学 Q2 NEUROSCIENCES
Price E Dickson, Udita Datta, Troy D Wilcox, Ashley A Auth, Robyn L Ball, Matt Dunn, Heidi S Fisher, Alyssa Klein, Michael R Leonardo, Tyler A Roy, Michael C Saul, Jason A Bubier, Leona H Gagnon, Vivek M Philip, Lisa M Tarantino, James D Jentsch, Elissa J Chesler
{"title":"Behavioral variation across multiple phases of intravenous cocaine self-administration among genetically diverse mouse populations.","authors":"Price E Dickson, Udita Datta, Troy D Wilcox, Ashley A Auth, Robyn L Ball, Matt Dunn, Heidi S Fisher, Alyssa Klein, Michael R Leonardo, Tyler A Roy, Michael C Saul, Jason A Bubier, Leona H Gagnon, Vivek M Philip, Lisa M Tarantino, James D Jentsch, Elissa J Chesler","doi":"10.1007/s00213-025-06904-w","DOIUrl":null,"url":null,"abstract":"<p><p>Genetic and other predisposing factors can influence the progression from initiation of drug intake to compulsive substance use through distinct biobehavioral processes. Operant cocaine self-administration studies in laboratory mice offer a powerful method to dissect the biology of this progression from initiation, dose-response, extinction, and cued reinstatement in a controlled, tractable system. However, many such studies encompass limited genetic diversity and rarely examine self-administration behaviors beyond the acquisition stage. Here, we study three high-diversity mouse populations - 50 strains from the Collaborative Cross (CC) reference panel, a large sample of Diversity Outbred (J: DO) population and their eight founder strains - to characterize the varied phenotypic manifestation of behaviors across multiple phases of cocaine intravenous self-administration (IVSA) in both sexes. We observed distinct strain differences among the founders and CC strains in all phases of self-administration, with heritability estimates ranging from 0 to 0.585 and many CC and J: DO phenotypic values exceeding the range of founders including the C57BL/6J strain. Sex differences were common across behaviors, some manifesting as main effects, others as strain interactions. Finally, by adopting a multi-stage design, we identified extreme strains for various cocaine intake and response traits. Together, these findings demonstrate the utility of extended self-administration protocols in high-diversity mouse populations and establish feasibility for their use in the discovery and characterization of biological mechanisms of substance use traits and for preclinical studies in relevant, complex mouse models.</p>","PeriodicalId":20783,"journal":{"name":"Psychopharmacology","volume":" ","pages":""},"PeriodicalIF":3.3000,"publicationDate":"2025-09-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Psychopharmacology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s00213-025-06904-w","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"NEUROSCIENCES","Score":null,"Total":0}
引用次数: 0

Abstract

Genetic and other predisposing factors can influence the progression from initiation of drug intake to compulsive substance use through distinct biobehavioral processes. Operant cocaine self-administration studies in laboratory mice offer a powerful method to dissect the biology of this progression from initiation, dose-response, extinction, and cued reinstatement in a controlled, tractable system. However, many such studies encompass limited genetic diversity and rarely examine self-administration behaviors beyond the acquisition stage. Here, we study three high-diversity mouse populations - 50 strains from the Collaborative Cross (CC) reference panel, a large sample of Diversity Outbred (J: DO) population and their eight founder strains - to characterize the varied phenotypic manifestation of behaviors across multiple phases of cocaine intravenous self-administration (IVSA) in both sexes. We observed distinct strain differences among the founders and CC strains in all phases of self-administration, with heritability estimates ranging from 0 to 0.585 and many CC and J: DO phenotypic values exceeding the range of founders including the C57BL/6J strain. Sex differences were common across behaviors, some manifesting as main effects, others as strain interactions. Finally, by adopting a multi-stage design, we identified extreme strains for various cocaine intake and response traits. Together, these findings demonstrate the utility of extended self-administration protocols in high-diversity mouse populations and establish feasibility for their use in the discovery and characterization of biological mechanisms of substance use traits and for preclinical studies in relevant, complex mouse models.

在基因不同的小鼠种群中,静脉注射可卡因自我给药的多个阶段的行为变化。
遗传和其他易感因素可以通过不同的生物行为过程影响从开始药物摄入到强迫性物质使用的进展。在实验室小鼠中进行的操作性可卡因自我给药研究提供了一种强有力的方法,可以在可控的、可处理的系统中解剖这种从起始、剂量反应、消失和提示恢复的生物学过程。然而,许多此类研究包含有限的遗传多样性,并且很少检查获得阶段之后的自我管理行为。在这里,我们研究了三个高多样性的小鼠种群——来自合作交叉(CC)参考小组的50个菌株,一个大样本的多样性近交系(J: DO)种群及其8个始祖菌株——来表征两性在可卡因静脉内自我给药(IVSA)的多个阶段行为的不同表型表现。在给药的各个阶段,我们观察到创建者和CC菌株之间存在明显的菌株差异,遗传力估计范围在0 ~ 0.585之间,许多CC和J: DO表型值超过创建者的范围,包括C57BL/6J菌株。性别差异在行为中很常见,一些表现为主要影响,另一些表现为压力相互作用。最后,通过采用多阶段设计,我们确定了各种可卡因摄入和反应特征的极端菌株。总之,这些发现证明了扩展自我给药方案在高多样性小鼠种群中的效用,并为其在物质使用特征的生物学机制的发现和表征以及相关的复杂小鼠模型的临床前研究中建立了可行性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Psychopharmacology
Psychopharmacology 医学-精神病学
CiteScore
7.10
自引率
5.90%
发文量
257
审稿时长
2-4 weeks
期刊介绍: Official Journal of the European Behavioural Pharmacology Society (EBPS) Psychopharmacology is an international journal that covers the broad topic of elucidating mechanisms by which drugs affect behavior. The scope of the journal encompasses the following fields: Human Psychopharmacology: Experimental This section includes manuscripts describing the effects of drugs on mood, behavior, cognition and physiology in humans. The journal encourages submissions that involve brain imaging, genetics, neuroendocrinology, and developmental topics. Usually manuscripts in this section describe studies conducted under controlled conditions, but occasionally descriptive or observational studies are also considered. Human Psychopharmacology: Clinical and Translational This section comprises studies addressing the broad intersection of drugs and psychiatric illness. This includes not only clinical trials and studies of drug usage and metabolism, drug surveillance, and pharmacoepidemiology, but also work utilizing the entire range of clinically relevant methodologies, including neuroimaging, pharmacogenetics, cognitive science, biomarkers, and others. Work directed toward the translation of preclinical to clinical knowledge is especially encouraged. The key feature of submissions to this section is that they involve a focus on clinical aspects. Preclinical psychopharmacology: Behavioral and Neural This section considers reports on the effects of compounds with defined chemical structures on any aspect of behavior, in particular when correlated with neurochemical effects, in species other than humans. Manuscripts containing neuroscientific techniques in combination with behavior are welcome. We encourage reports of studies that provide insight into the mechanisms of drug action, at the behavioral and molecular levels. Preclinical Psychopharmacology: Translational This section considers manuscripts that enhance the confidence in a central mechanism that could be of therapeutic value for psychiatric or neurological patients, using disease-relevant preclinical models and tests, or that report on preclinical manipulations and challenges that have the potential to be translated to the clinic. Studies aiming at the refinement of preclinical models based upon clinical findings (back-translation) will also be considered. The journal particularly encourages submissions that integrate measures of target tissue exposure, activity on the molecular target and/or modulation of the targeted biochemical pathways. Preclinical Psychopharmacology: Molecular, Genetic and Epigenetic This section focuses on the molecular and cellular actions of neuropharmacological agents / drugs, and the identification / validation of drug targets affecting the CNS in health and disease. We particularly encourage studies that provide insight into the mechanisms of drug action at the molecular level. Manuscripts containing evidence for genetic or epigenetic effects on neurochemistry or behavior are welcome.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信